TCL Archive In Brief: No Such Thing As Premature Data, Fisher Says- Only Immature Evaluation, Premature Application June 20, 1980
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner. June 2, 2006
TCL Archive FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections August 18, 1978
